STOCK TITAN
  1. Home
  2. Sec-filings
  3. ALHC
  4. [Form 4] Alignment Healthcare, Inc. Insider Trading Activity

Alignment Healthcare insider tax-withholding sales: 30,939 shares on 09/10/2025

Filing Impact
(Very High)
Filing Sentiment
(Negative)
Form Type
4

Rhea-AI Filing Summary

Alignment Healthcare insider Christopher J. Joyce, the companys Chief Legal and Administrative Officer and a director, reported two non-discretionary sales of common stock on 09/10/2025 to satisfy tax withholding for vested restricted stock units. Mr. Joyce sold 22,128 shares at a weighted-average price of $16.2293 (per-share trades ranged $15.74$16.735) and 8,811 shares at a weighted-average price of $16.8555 (per-share trades ranged $16.74$17.24). After these transactions he beneficially owns 352,403 and 343,592 shares as reported on each line, respectively. The filer certified the sales were to cover tax withholding and not discretionary trades.

Positive

  • None.

Negative

  • None.

Insights

TL;DR Insider sold shares to cover tax withholding from RSU vesting; transactions appear non-discretionary and routine.

The Form 4 shows Mr. Joyce executed two sales on 09/10/2025 that he identifies as sales to satisfy tax withholding obligations tied to restricted stock unit vesting. The filing discloses weighted-average sale prices and price ranges for the multiple underlying trades, and retains detailed beneficial ownership counts after the sales. For investors, this is a common administrative sale rather than an indicated change in strategic ownership. The disclosure and willingness to provide transaction-level pricing on request improve transparency.

TL;DR Reporting is compliant and transparent; nature of sale reduces governance concern.

The report identifies the reporting persons role and relationship to the issuer and clearly states the sales were to cover tax withholding from vested RSUs, a typical practice. The inclusion of weighted-average prices and price ranges, plus an undertaking to provide per-trade details on request, meets disclosure expectations. There is no indication of discretionary trading activity or unusual timing in the filing itself.

Insider JOYCE CHRISTOPHER J
Role Chief Legal and Admin. Officer
Sold 30,939 shs ($508K)
Type Security Shares Price Value
Sale Common Stock 22,128 $16.2293 $359K
Sale Common Stock 8,811 $16.8555 $149K
Holdings After Transaction: Common Stock — 352,403 shares (Direct)
Footnotes (1)
  1. Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units. This transaction does not represent a discretionary trade by the reporting person. The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $15.74 to $16.735. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range. The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $16.74 to $17.24. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range.
Form 4 Insider Transactions: What Each Field Means →
SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
JOYCE CHRISTOPHER J
(Last) (First) (Middle)
1100 W. TOWN & COUNTRY RD.
SUITE 1600
(Street)
ORANGE CA 92868
(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Alignment Healthcare, Inc. [ ALHC ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
Chief Legal and Admin. Officer
3. Date of Earliest Transaction (Month/Day/Year)
09/10/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
 6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 09/10/2025 S 22,128(1) D $16.2293(2) 352,403 D
Common Stock 09/10/2025 S 8,811(1) D $16.8555(3) 343,592 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units. This transaction does not represent a discretionary trade by the reporting person.
2. The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $15.74 to $16.735. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range.
3. The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $16.74 to $17.24. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range.
Remarks:
/s/ Christopher J. Joyce 09/10/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Source: View Original Filing on SEC EDGAR

FAQ

What did Christopher J. Joyce report on Form 4 for ALHC?

He reported two sales on 09/10/2025 to cover tax withholding from vested RSUs: 22,128 shares at a weighted-average price of $16.2293 and 8,811 shares at a weighted-average price of $16.8555.

Were the reported sales discretionary trades?

No. The filing explicitly states the shares were sold to satisfy tax withholding obligations related to RSU vesting and were not discretionary trades by the reporting person.

How many shares does the reporting person beneficially own after the transactions?

The Form 4 lists beneficial ownership of 352,403 shares on the first line and 343,592 shares on the second line following the reported transactions.

What price ranges were the shares sold within?

For the 22,128-share sale the per-share trades ranged from $15.74 to $16.735; for the 8,811-share sale the range was $16.74 to $17.24.

What is the reporting person's role at Alignment Healthcare (ALHC)?

Christopher J. Joyce is reported as a Director and the company's Chief Legal and Administrative Officer.